Repositioning involves several steps, starting with the identification of potential drug candidates. Researchers use various bioinformatics tools and databases to screen for drugs that might have anti-cancer properties. Once potential candidates are identified, they undergo preclinical studies to test their efficacy in cancer models. Drugs showing promise then move to clinical trials to confirm their effectiveness and safety in cancer patients.
